Observational study of transplanted individuals in Switzerland
Official title: Swiss Transplant Cohort Study
Run by University of Zurich · NCT01204944 · Data updated 2026-11-12
This study is looking at people in Switzerland who have received organ or stem cell transplants to see how their health and well-being are affected over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 0 Years to 100 Years |
| Sex | All |
| Enrollment | 7500 (estimated) |
| Sponsor | University of Zurich Academic / other |
| Locations | 1 site (Zurich) |
| Status | Recruiting |
| Started | May 2008 |
| Main results expected | May 2028 |
| Study ends | May 2028 |
| Registry record updated | April 1, 2025 |
| Trial ID | NCT01204944 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are all individuals who have received solid organ or stem cell transplants in Switzerland.
✕Probably not a fit
Patients who do not provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Swiss Transplant Cohort Study is an observational prospective cohort study that enrolls all patients who have undergone solid organ and stem cell transplantation in Switzerland since May 2008. It collects predefined variables at specific time points, focusing on immunological and infectious complications, as well as psychosocial factors. Individual biological samples, including PBMC, plasma, and DNA, are stored for future research projects. This comprehensive data collection aims to enhance understanding of transplantation outcomes.
Why it matters
Potential benefit: If successful, this study could improve the management and outcomes of transplant patients by identifying key factors affecting their health.
How similar studies have gone: Other observational studies in transplantation have shown success in identifying critical factors affecting patient outcomes, suggesting that this approach is validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * All patients after organ and stem cell (planned 2009) transplantation. Exclusion criteria: * No informed consent given
Where it's running
- Zurich, Switzerland Recruiting
Study contacts
- Study coordinator: 01 Studienregister MasterAdmins
- Phone: +41 (0)44 255 11 11
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Long-term outcomes after vacuum-induced tamponade for postpartum hemorrhage
This study will look at women who had postpartum hemorrhage treated with vacuum-induced tamponade at a Zurich hospital to see how they fared over time, including future pregnancies and fertility.
-
Add-on Sildenafil Before Exercise in PAH to See if Max Workload Improves
This study tests whether taking 20 mg sildenafil right before exercise helps people with pulmonary arterial hypertension perform more work during cardiopulmonary testing.
-
Fatigue Investigation Using Digital Outcomes
This study tests whether digital monitoring with a smartphone app and wearables can track fatigue in people with MS or long COVID, compared with healthy volunteers.
-
Impact of ambient air vs nasal liquid oxygen on exercise performance in pulmonary vascular disease
This study tests whether using nasal liquid oxygen during a 6-minute walk test changes how far patients with PAH or CTEPH can walk compared to breathing room air.
-
Liquid oxygen vs ambient air during a 6-minute walk in people with pulmonary vascular disease
This study tests whether walking with liquid oxygen at about 4 L/min helps or hinders distance walked compared with walking on room air in adults with PAH or CTEPH living in Switzerland.
-
Daily adjustment of radiation dose in MRI-guided SBRT for abdominal and pelvic tumors
This trial tests whether adjusting the radiation dose in real-time during MRI-guided SBRT improves targeting for abdominal or pelvic tumors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.